The impact of angiotensin receptor blockers on arterial stiffness: A meta-analysis

Hypertension Research

Volumn 38, Issue 9, 2015, Pages 613-620

  Peng, Feng ^a   Pan, Hongming ^b   Wang, Bin ^b   Lin, Jinxiu ^a   Niu, Wenquan ^c  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

angiotensin receptor blocker; arterial stiffness; blood pressure; meta analysis; pulse wave velocity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BERAPROST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; EPLERENONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LOSARTAN; RENIN INHIBITOR; TELMISARTAN; VALSARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; BRACHIAL ANKLE PULSE WAVE; CAROTID FEMORAL PULSE WAVE; DIASTOLIC BLOOD PRESSURE; HEART RATE; HUMAN; META ANALYSIS; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ANKLE BRACHIAL INDEX; DRUG EFFECTS; HEMODYNAMICS; HYPERTENSION; PATHOPHYSIOLOGY;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANKLE BRACHIAL INDEX; HEMODYNAMICS; HUMANS; HYPERTENSION; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84933188990     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.51     Document Type: Article

References (54)

1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55: 1318-1327.
2. Otsuka K, Fukuda S, Shimada K, Suzuki K, Nakanishi K, Yoshiyama M, Yoshikawa J. Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease. Hypertens Res 2014; 37: 1014-1020.
3. Seidlerova J, Filipovsky J, Mayer O, Wohlfahrt P, Cifkova R. Positive effects of antihypertensive treatment on aortic stiffness in the general population. Hypertens Res 2014; 37: 64-68.
4. Wolf G. Free radical production and angiotensin. Curr Hypertens Rep 2000; 2: 167-173.
5. Otsuka T, Munakata R, Kato K, Kodani E, Ibuki C, Kusama Y, Seino Y, Kawada T. Oscillometric measurement of brachial artery cross-sectional area and its relationship with cardiovascular risk factors and arterial stiffness in a middle-aged male population. Hypertens Res 2013; 36: 910-915.
6. Shirai K, Utino J, Saiki A, Endo K, Ohira M, Nagayama D, Tatsuno I, Shimizu K, Takahashi M, Takahara A. Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI). Curr Hypertens Rev 2013; 9: 66-75.
7. Kim EJ, Song WH, Lee JU, Shin MS, Lee S, Kim BO, Hong KS, Han SW, Park CG, Seo HS. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study. Hypertens Res 2014; 37: 50-56.
8. Mahmud A, Feely J. Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens 2002; 15: 1092-1095.
9. Kim JH, Oh SJ, Lee JM, Hong EG, Yu JM, Han KA, Min KW, Son HS, Chang SA. The effect of an Angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension. Diabetes Metab J 2011; 35: 236-242.
10. Hayoz D, Zappe DH, Meyer MA, Baek I, Kandra A, Joly MP, Mazzolai L, Haesler E, Periard D. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen. J Clin Hypertens (Greenwich) 2012; 14: 773-778.
11. Kim EJ, Song WH, Lee JU, Shin MS, Lee S, Kim BO, Hong KS, Han SW, Park CG, Seo HS. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study. Hypertens Res 2013; 37: 50-6.
12. Nakamura T, Inoue T, Suzuki T, Kawagoe Y, Ueda Y, Koide H, Node K. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency. Hypertens Res 2008; 31: 841-850.
13. Spanos G, Kalaitzidis R, Karasavvidou D, Pappas K, Siamopoulos KC. Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: a randomized parallelgroup study. J Renin Angiotensin Aldosterone Syst 2012; 14: 315-21.
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269 W264.
15. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007; 28: 105-114.
16. Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 2011; 11: 41.
17. Ishii H, Tsukada T, Yoshida M. Angiotensin II type-I receptor blocker, candesartan, improves brachial-ankle pulse wave velocity independent of its blood pressure lowering effects in type 2 diabetes patients. Intern Med 2008; 47: 2013-2018.
18. Mitsuhashi H, Tamura K, Yamauchi J, Ozawa M, Yanagi M, Dejima T, Wakui H, Masuda S, Azuma K, Kanaoka T, Ohsawa M, Maeda A, Tsurumi-Ikeya Y, Okano Y, Ishigami T, Toya Y, Tokita Y, Ohnishi T, Umemura S. Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. Atherosclerosis 2009; 207: 186-190.
19. Han SH, Kang EW, Yoon SJ, Yoon HS, Lee HC, Yoo TH, Choi KH, Han DS, Kang SW. Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2011; 26: 3722-3728.
20. Tomiyama H, Yoshida M, Yamada J, Matsumoto C, Odaira M, Shiina K, Yamashina A. Arterial-cardiac destiffening following long-term antihypertensive treatment. Am J Hypertens 2011; 24: 1080-1086.
21. Lunder M, Janic M, Sabovic M. Reduction of age-associated arterial wall changes by low-dose valsartan. Eur J Prev Cardiol 2012; 19: 1243-1249.
22. Shigenaga A, Tamura K, Dejima T, Ozawa M, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Mitsuhashi H, Okano Y, Kokuho T, Sugano T, Ishigami T, Toya Y, Uchino K, Tokita Y, Umemura S. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis. Nephron Clin Pract 2009; 112: c31-40.
23. Agnoletti D, Zhang Y, Borghi C, Blacher J, Safar ME. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation. Am J Hypertens 2013; 26: 1045-1052.
24. Ihm SH, Jeon HK, Chae SC, Lim DS, Kim KS, Choi DJ, Ha JW, Kim DS, Kim KH, Cho MC, Baek SH. Belasco trial investigators RoK. Benidipine has effects similar to losartan on the central blood pressure and arterial stiffness in mild to moderate essential hypertension. Chin Med J (Engl) 2013; 126: 2021-2028.
25. Anan F, Takahashi N, Ooie T, Yufu K, Hara M, Nakagawa M, Yonemochi H, Saikawa T, Yoshimatsu H. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. Eur J Clin Pharmacol 2005; 61: 353-359.
26. Asmar R, Gosse P, Topouchian J, N'Tela G, Dudley A, Shepherd GL. Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension. J Renin Angiotensin Aldosterone Syst 2002; 3: 176-180.
27. Ichihara A, Hayashi M, Kaneshiro Y, Takemitsu T, Homma K, Kanno Y, Yoshizawa M, Furukawa T, Takenaka T, Saruta T. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis 2005; 45: 866-874.
28. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients. J Hum Hypertens 2006; 20: 787-794.
29. Kosch M, Levers A, Lang D, Bartels V, Rahn KH, Pavenstadt H, Hausberg M. A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension. Nephrol Dial Transplant 2008; 23: 2280-2285.
30. Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens 2002; 15: 321-325.
31. Morimoto S, Yano Y, Maki K, Sawada K. Renal and vascular protective effects of telmisartan in patients with essential hypertension. Hypertens Res 2006; 29: 567-572.
32. Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, Yoshinaga K, Toyota T. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004; 17: 1050-1055.
33. Nakayama T, Masubuchi Y, Kawauchi K, Masaki R, Hironaga T, Ishima H, Torigoe M, Shimabukuro H. Beneficial effect of beraprost sodium plus telmisartan in the prevention of arterial stiffness development in elderly patients with hypertension and cerebral infarction. Prostaglandins Leukot Essent Fatty Acids 2007; 76: 309-314.
34. Rajagopalan S, Kariisa M, Dellegrottaglie S, Bard RL, Kehrer C, Matlow S, Daley W, Pitt B, Brook R. Angiotensin receptor blockade improves vascular compliance in healthy normotensive elderly individuals: results from a randomized double-blind placebocontrolled trial. J Clin Hypertens (Greenwich) 2006; 8: 783-790.
35. Rehman A, Ismail SB, Naing L, Roshan TM, Rahman AR. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile. Am J Hypertens 2007; 20: 184-189.
36. Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. Adv Perit Dial 2003; 19: 59-66.
37. Takami T, Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003; 26: 609-614.
38. Feng W. Effect of telmisartan and amlodipine on artery elastic function in essential hypertensive patients. Chin J Clin Res 2011; 1: 810-811.
39. He L, Wei C, Zheng Z. Impact of ARB on arterial stiffness in female hypertensive patients with impaired glucose tolerance. Chin J Clin Cardiol 2011; 27: 158-159.
40. Huang R, Liu T, Gao Y, Zhen Y. Effect of eplerenone and losartan on arterial stiffness and insulin-like growth factor 1 in patients with mild to moderate essential hypertension. Chin J Clin Cardiol 2013; 29: 64-67.
41. Kong H, Li Y, Zhuang Q, Li X. Effect of benazepril, felodipine and rbesartan on blood pressure and brachial-ankle pulse wave velocity in essential hypertensive patients. Chin Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease 2012; 20: 1657-1658.
42. Li Y, Ma S. Comparative Study of telmisartan and amlodipine improving arterial stifness in type 2 diabetes mellitus patients with hypertension. Chin J Arterioscler 2013; 21: 252-256.
43. Li Y, Shu M, Du M. Pedndopril, amlodipine and telmisartan improve arterial stifness in patients with hypertension. Chin J Cardiol 2009; 37: 908-912.
44. Li Y, Wang H. Effect of various antihypertensive drugs on the improvement of pulse wave velocity in patients with light-to- moderate essential hypertension. Chin New Med 2010; 41: 448-451.
45. Long D, Liu Q. Impact of valsartan on arterial stiffness in patients with coronary heart disease and hypertension. J Clin Res 2010; 27: 436-438.
46. Ruan C, Chen R, Li Z. The change of peripheral vascular function in patients with congestive heart failure and the effect of irbesartan intervention. Med J Chin People Health 2009; 21: 226-228.
47. Ruan C, Chen R, Wang Z. The change of peripheral vascular function in patients with hypertension and the effect of candesartan intervention. Med J Chin People Health 2010; 22: 1069-1070.
48. Wu Z, Qi H, Sheng G. Study on difference of various antihypertensive drugs on pulse wave velocity and correlation with high Sensitivity C-Reactive Protein and von Willebrand Factor. Chin J Arterioscler 2011; 19: 693-696.
49. Yang P, Yu H, Wei T. Effects of valsartan on large artery elasticity in patients with essential hypertension. Chin J Exp Tradition Med Formula 2012; 18: 256-259.
50. Zhao W. Effect of valsartan on artery elastic function in elder essential hypertensive patients. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease 2007; 15: 767-768.
51. Zheng X, Lin J. Effects of various antihypertensive drugs on arterial elasticity in patients with essential hypertension. Chin J Hypertens 2008; 16: 404-407.
52. Weir MR, Dzau VJ. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 1999; 12: 205S-213S.
53. Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis 2012; 221: 18-33.
54. Hannah RR, Alexander JS, Michael B. Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments. Wiley, New York, USA, 2005, P105.